iOmics Ltd was born from a consortium which came together to develop diagnostic platforms based on omics technologies to address major issues in the clinical and agrifood areas.
The strength and expertise of this new venture with its combined scientific and diagnostic systems knowledge is also enabling it to explore many other human and animal disease challenges, and projects are already in hand in these areas:
- Lung cancer screening
- Bovine TB
- Human TB
- Respiratory disease
- Urogenital disease and prostate cancer
The founders represent companies and individuals working at the very edge of advanced science, technology and processes giving
iOmics the advantage of tightly focused vision on each project and the means to achieve it with one strong management team.